MRNA research enabled the remarkably fast production of COVID-19 vaccine candidates in the pandemic ... defending the body ...

The influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that despite seasonally updated ...

Allen Institute scientists are learning why vaccines can trigger a weaker response in older adults, around age 65, and what ...

With the demand for human donor organs desperately outstripping supply, scientists are working to see if genetically edited ...

Some conservation groups are calling for an effective ban on genetic modification, but others say these technologies are ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...

And most ‘humanized’ mice (which have human genes, cells or tissues) don’t mount enough antibodies to fight infections, which is a problem for researchers who study vaccines and immune ... Voss and ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: 4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA) ...